ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Novartis
OHSU Knight Cancer Institute
Barbara Ann Karmanos Cancer Institute
Jonsson Comprehensive Cancer Center
Bristol-Myers Squibb
University of Massachusetts, Worcester
University of Pittsburgh
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Jonsson Comprehensive Cancer Center